F
Frédéric Charlotte
Researcher at University of Paris
Publications - 315
Citations - 27482
Frédéric Charlotte is an academic researcher from University of Paris. The author has contributed to research in topics: Liver biopsy & Histiocytosis. The author has an hindex of 75, co-authored 295 publications receiving 24972 citations. Previous affiliations of Frédéric Charlotte include Centre national de la recherche scientifique & Oregon Health & Science University.
Papers
More filters
Journal Article
Nonepidermotropic cutaneous lymphomas : a histopathological and immunohistological study of 52 cases
Frédéric Charlotte,Janine Wechsler,Pascal Joly,Martine Bagot,Lessana-Leibowitch M,Philippe Gaulard,E. S. Zafrani +6 more
TL;DR: This study shows that nonepidermotropic cutaneous lymphomas are B-cell lymphomas in 75% of the cases, most often of the large-cell type, and emphasizes the value of immunohistochemistry to firmly establish malignancy when routine light microscopical findings are questionable.
Journal ArticleDOI
F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain
Gaëlle Guettrot-Imbert,Julien Haroche,Gilles Grimon,Frédéric Charlotte,Jacques Ninet,Stefano Possenti,Antony Kelly,Zahir Amoura,Olivier Aumaître,Marc André +9 more
TL;DR: Although nonspecific, FDG-PET/CT may be an interesting tool for the diagnosis and management of recurrent and febrile abdominal pain in AA at the time of relapse, it can differentiate between a sequela of previous flares and a new localization.
Journal ArticleDOI
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier.
R. Karkouche,Saskia Ingen-Housz-Oro,Sabine Le Gouvello,Frédéric Charlotte,Marina Thomas,Ouidad Zehou,Valérie Frenkel,David Boutboul,Olivier Chosidow,Eric Caumes,Philippe Gaulard,Nicolas Ortonne +11 more
TL;DR: The possible role of immunosuppression and/or HIV in oncogenesis can be postulated, as patients infected with HIV may develop anti‐HIV cytotoxic CD8+ lymphoproliferations.
Journal ArticleDOI
Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe
Marie Parrens,Antoine Martin,Laurence Lamant,Richard Delarue,Corinne Haioun,Olivier Tournilhac,Francoise Berger,Céline Bossard,Brigitte Bouchindhomme,Josette Brière,Danielle Canioni,Frédéric Charlotte,Bettina Fabiani,Thierry Jo Molina,Martine Patey,Tony Petrella,Jean-Michel Picquenot,Thérèse Rousset,Virginie Fataccioli,Georges Delsol,Laurence de Leval,Philippe Gaulard +21 more
TL;DR: To characterize the epidemiology of mature T/NK-cell malignancies in Western Europe (France and bordering countries) and to examine whether the availability of new tools/antibodies and changing concepts over the past years might have translated into an apparent change in the relative distribution of PTCL entities is examined.
Journal ArticleDOI
Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.
A. Amoura,Julien Haroche,Jean-François Emile,Stéphane Barete,Z. Helias-Rodzewicz,Frédéric Charlotte,Thierry Maisonobe,Zahir Amoura,F. Cohen Aubart +8 more
TL;DR: A single-center retrospective study among adult patients with Erdheim-Chester disease treated with BRAF and/or MEK inhibitors between 2012 and 2018 found four patients had clinical manifestations of sarcoidosis occurring under targeted therapy.